Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Agreed, the difference between our current price and a valuation back to where we were year ago ($7 to $8) is a deal on AXAL or HOT. I'm optimistic Berlin will get it done. He's a real CEO and his responsible focus on cost control and shareholder alignment is something we haven't seen in the last four years. The valuation now, net of cash, is valuing the company at virtually nothing because of poor management in the past. New leadership, new era, the market will catch up IMO.